6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Pharmacotherapy and Medication-Assisted Treatment
Pharmacological approaches to treating addiction are evolving rapidly, with growing evidence supporting the efficacy of medication-assisted interventions for diverse substances. Pharmacotherapy and medication-assisted treatment have transformed recovery trajectories for individuals struggling with opioids, alcohol, and even nicotine. Agents like buprenorphine, methadone, and naltrexone help mitigate withdrawal symptoms and reduce cravings while stabilizing long-term outcomes. Integration of behavioral support enhances the efficacy of these medications, providing a more comprehensive care pathway. Clinicians now focus on individualized treatment planning, ensuring the right pharmacological support is matched with the patient's physiological and psychological needs. As stigma diminishes, accessibility and adherence rates continue to improve.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States